The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

candcvision.com

Founded Year

1998

Stage

Acquired | Acquired

Total Raised

$43.5M

About eyeonics

Unlike standard cataract replacement lenses, Crystalens lenses correct their cataracts and give users back their range of vision. They flex like their eye's natural lens, allowing users to see better at all distances.

eyeonics Headquarter Location

26970 Aliso Viejo Parkway Suite 100

Aliso Viejo, California, 92656,

United States

949-916-9352

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest eyeonics News

09:43 ET CORD, LLC Completes One-Year Follow-Up on Subjects From the Model SC9 Intraocular Lens FDA Clinical Trial

Nov 11, 2021

News provided by Share this article Share this article ALISO VIEJO, Calif., Nov. 11, 2021 /PRNewswire/ -- CORD, LLC, a privately held ophthalmic medical device company, today announced results from its one-year follow-up on patients who were implanted with the Model SC9 intraocular lens (IOL) in a clinical trial. The trial was performed under an Investigational Device Exemption (IDE) with the U.S. Food and Drug Administration (FDA) for the treatment of cataracts. This important milestone enables the company to file a Premarket Approval (PMA) application to secure FDA approval for the commercial distribution of the Model SC9 in the United States. The Model SC9 Intraocular Lens Cataracts, a consequence of aging, are a clouding over of the lens of the eyes, causing blurry vision. A treatment for cataracts is the surgical implantation of an IOL. While this common, minimally invasive surgical procedure is extremely effective at restoring vision, it comes with limitations, such as the continued need for glasses to correct imperfect intermediate and near vision; glare or halos that compromise distance vision; loss of contrast sensitivity; or loss of binocular vision. ABOUT THE MODEL SC9 INTRAOCULAR LENS The clinical trial, which included 17 eyes in 15 patients implanted with the Model SC9 lens, was conducted by Dr. Juan Batlle, MD, at the Centro de Microcirugia Ocular y Laser in the Dominican Republic. Results from the one-year follow-up demonstrated: Distance corrected near visual acuity (DCNVA) of 20/40 or better in 14 of the 16 eyes available at 12 months (87%). Uncorrected near and intermediate visual acuity (UCNVA and UCIVA) of 20/40 or better in 14 of the 16 eyes available at 12 months (87%). Postsurgical vision that was better than before the procedure, even with the use of glasses and contact lenses, for all participants. Uncorrected distance visual acuity – meaning natural vision with no vision aids – was at least 20/40 in all eyes implanted with the SC9 lens. "Dr. Cumming has done it again," said John Hovanesian of Harvard Eye Associates in Laguna Hills, California. "As one of the leading pioneers of IOL development, with the Model SC9 he's showing that he has even more to offer the field of ophthalmology. This new lens offers patients a range of vision with a perfectly focused image." ABOUT CORD, LLC AND INVENTOR STUART CUMMING, MD Cumming Ophthalmic Research and Development (aka CORD, LLC) is a privately held ophthalmic medical device company founded by Dr. Stuart Cumming, MD. The Model SC9 represents Dr. Cumming's latest breakthrough in vision technology. After developing the design of the Crystalens and conducting clinical trials in Germany, Dr. Cumming co-founded Eyeonics in 1998. The Crystalens was approved by the FDA in November 2003 as the first and only accommodating IOL. Eyeonics was purchased by Bausch + Lomb in 2008. The Model SC9 lens is the result of 28 years of research, coupled with Dr. Cumming's expertise and continued devotion to IOL research and development. Media Contact

  • When was eyeonics founded?

    eyeonics was founded in 1998.

  • Where is eyeonics's headquarters?

    eyeonics's headquarters is located at 26970 Aliso Viejo Parkway, Aliso Viejo.

  • What is eyeonics's latest funding round?

    eyeonics's latest funding round is Acquired.

  • How much did eyeonics raise?

    eyeonics raised a total of $43.5M.

  • Who are the investors of eyeonics?

    Investors of eyeonics include Bausch & Lomb, Brentwood Associates, Pequot Venture Capital, Versant Ventures, ABS Ventures and 3 more.

  • Who are eyeonics's competitors?

    Competitors of eyeonics include Visioneering Technologies, Powervision, Paragon Medical, Corpora Systems, VisionCare Ophthalmic Technologies and 13 more.

You May Also Like

O
Otothera Corporation

Otothera Corporation is a medical device company developing products to diagnose and treat the more than seven million severe tinnitus (constant ringing in the ears) sufferers in the US. The company was originally named AudioFusion. The company was a 2006 PTEN Growth Accelerator (GAP) winner.

ImpediMed Logo
ImpediMed

ImpediMed is a medical device company focusing on bioimpedance.

TheraTogs Logo
TheraTogs

TheraTogs, based in Telluride, Colorado, is a medical device company offering orthotic undergarment and strapping systems that give users with sensorimotor impairment modality for improving postural alignment and stability movement skill and precision and joint stability.

Exergen Logo
Exergen

Exergen Corporation is the recognized world leader in industrial and medical non-invasive temperature technology. From providing temperature sensors for NASA and various industries to creating one of the world's most popular baby gifts, Exergen creates non-invasive temperature measurement devices providing lower cost, higher accuracy, less invasiveness, and greater reliability than ever previously possible. The creator of a temporal artery thermometer-the Temporal Scanner, the most efficacious, non-invasive thermometer ever created. Exergen holds over 100 U.S. and foreign patents, and is the only manufacturer of retail medical thermometers in the U.S. Presently, 30% of hospitals and pediatricians currently use the Exergen TemporalScanner, and well over 1 million consumers use one at home. Founded by Harvard-research scientist .Dr. Francesco Pompei over two decades ago, Exergen Corporation is based in Watertown, Massachusetts, USA.

O
Ost Medical

The company are a enterprise recognized in the enteral products industry as a manufacturer of high quality, yet cost-effective devices. The company supply products to domestic and international customers. The company also are a contract manufacturer focused on the development and production of equipment for the medical and life sciences industries. The company's organization is composed of individuals with years of industry experience. OST Medical has a strong commitment to the company's customers and the company are confident in the company's ability to meet customer expectations in quality, price and delivery.

S
Sofamor Danek Group

Medtronic Sofamor Danek's is focused on solutions for spinal and cranial surgeons. The company has offices located in Memphis, Tennessee, Louisville, Colorado, Warsaw, Indiana, Deggendorf, Germany, and Paris, France, and more than 1,800 associates around the world, per the company.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.